These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

261 related articles for article (PubMed ID: 21295028)

  • 1. In vitro modelling of Alzheimer's disease: degeneration and cell death induced by viral delivery of amyloid and tau.
    Stoppelkamp S; Bell HS; Palacios-Filardo J; Shewan DA; Riedel G; Platt B
    Exp Neurol; 2011 Jun; 229(2):226-37. PubMed ID: 21295028
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Non-tau based neuronal degeneration in Alzheimer's disease -- an immunocytochemical and quantitative study in the supragranular layers of the middle temporal neocortex.
    van de Nes JA; Nafe R; Schlote W
    Brain Res; 2008 Jun; 1213():152-65. PubMed ID: 18455153
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Accelerated amyloid deposition, neurofibrillary degeneration and neuronal loss in double mutant APP/tau transgenic mice.
    Ribé EM; Pérez M; Puig B; Gich I; Lim F; Cuadrado M; Sesma T; Catena S; Sánchez B; Nieto M; Gómez-Ramos P; Morán MA; Cabodevilla F; Samaranch L; Ortiz L; Pérez A; Ferrer I; Avila J; Gómez-Isla T
    Neurobiol Dis; 2005 Dec; 20(3):814-22. PubMed ID: 16125396
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cellular model of Alzheimer's disease--relevance to therapeutic testing.
    Marwarha G; Ghribi O
    Exp Neurol; 2012 Feb; 233(2):733-9. PubMed ID: 22119424
    [No Abstract]   [Full Text] [Related]  

  • 5. Inverse and distinct modulation of tau-dependent neurodegeneration by presenilin 1 and amyloid-beta in cultured cortical neurons: evidence that tau phosphorylation is the limiting factor in amyloid-beta-induced cell death.
    Leschik J; Welzel A; Weissmann C; Eckert A; Brandt R
    J Neurochem; 2007 Jun; 101(5):1303-15. PubMed ID: 17298384
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alpha1-antichymotrypsin, an inflammatory protein overexpressed in Alzheimer's disease brain, induces tau phosphorylation in neurons.
    Padmanabhan J; Levy M; Dickson DW; Potter H
    Brain; 2006 Nov; 129(Pt 11):3020-34. PubMed ID: 16987932
    [TBL] [Abstract][Full Text] [Related]  

  • 7. β-Amyloid precursor protein and tau protein levels are differently regulated in human cerebellum compared to brain regions vulnerable to Alzheimer's type neurodegeneration.
    Caušević M; Farooq U; Lovestone S; Killick R
    Neurosci Lett; 2010 Nov; 485(3):162-6. PubMed ID: 20826196
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intracellular Aß triggers neuron loss in the cholinergic system of the APP/PS1KI mouse model of Alzheimer's disease.
    Christensen DZ; Bayer TA; Wirths O
    Neurobiol Aging; 2010 Jul; 31(7):1153-63. PubMed ID: 18771817
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Truncated tau from sporadic Alzheimer's disease suffices to drive neurofibrillary degeneration in vivo.
    Zilka N; Filipcik P; Koson P; Fialova L; Skrabana R; Zilkova M; Rolkova G; Kontsekova E; Novak M
    FEBS Lett; 2006 Jun; 580(15):3582-8. PubMed ID: 16753151
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A NH2 tau fragment targets neuronal mitochondria at AD synapses: possible implications for neurodegeneration.
    Amadoro G; Corsetti V; Stringaro A; Colone M; D'Aguanno S; Meli G; Ciotti M; Sancesario G; Cattaneo A; Bussani R; Mercanti D; Calissano P
    J Alzheimers Dis; 2010; 21(2):445-70. PubMed ID: 20571215
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Calcium-binding protein secretagogin-expressing neurones in the human hippocampus are largely resistant to neurodegeneration in Alzheimer's disease.
    Attems J; Preusser M; Grosinger-Quass M; Wagner L; Lintner F; Jellinger K
    Neuropathol Appl Neurobiol; 2008 Feb; 34(1):23-32. PubMed ID: 17961140
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Amyloid-beta precursor protein mediates neuronal toxicity of amyloid beta through Go protein activation.
    Sola Vigo F; Kedikian G; Heredia L; Heredia F; Añel AD; Rosa AL; Lorenzo A
    Neurobiol Aging; 2009 Sep; 30(9):1379-92. PubMed ID: 18187234
    [TBL] [Abstract][Full Text] [Related]  

  • 13. BAG-1M is up-regulated in hippocampus of Alzheimer's disease patients and associates with tau and APP proteins.
    Elliott E; Laufer O; Ginzburg I
    J Neurochem; 2009 May; 109(4):1168-78. PubMed ID: 19317853
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of the beta secretase-1 inhibitor on the amyloid C-terminal fragment of amyloid precursor protein processing in a hyperphosphorylated tau rat model.
    Chen HY; Wang L; Liu JF; Wang WZ; Yu CJ
    Genet Mol Res; 2014 Aug; 13(3):6213-27. PubMed ID: 25158248
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Region-specific dendritic simplification induced by Aβ, mediated by tau via dysregulation of microtubule dynamics: a mechanistic distinct event from other neurodegenerative processes.
    Golovyashkina N; Penazzi L; Ballatore C; Smith AB; Bakota L; Brandt R
    Mol Neurodegener; 2015 Nov; 10():60. PubMed ID: 26541821
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Amyloid-dependent triosephosphate isomerase nitrotyrosination induces glycation and tau fibrillation.
    Guix FX; Ill-Raga G; Bravo R; Nakaya T; de Fabritiis G; Coma M; Miscione GP; Villà-Freixa J; Suzuki T; Fernàndez-Busquets X; Valverde MA; de Strooper B; Muñoz FJ
    Brain; 2009 May; 132(Pt 5):1335-45. PubMed ID: 19251756
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Age-related accumulation of Reelin in amyloid-like deposits.
    Knuesel I; Nyffeler M; Mormède C; Muhia M; Meyer U; Pietropaolo S; Yee BK; Pryce CR; LaFerla FM; Marighetto A; Feldon J
    Neurobiol Aging; 2009 May; 30(5):697-716. PubMed ID: 17904250
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of APP trafficking by tau protein does not increase the generation of amyloid-beta peptides.
    Goldsbury C; Mocanu MM; Thies E; Kaether C; Haass C; Keller P; Biernat J; Mandelkow E; Mandelkow EM
    Traffic; 2006 Jul; 7(7):873-88. PubMed ID: 16734669
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phosphorylated tau in neuritic plaques of APP(sw)/Tau (vlw) transgenic mice and Alzheimer disease.
    Pérez M; Morán MA; Ferrer I; Avila J; Gómez-Ramos P
    Acta Neuropathol; 2008 Oct; 116(4):409-18. PubMed ID: 18679696
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transient intraneuronal A beta rather than extracellular plaque pathology correlates with neuron loss in the frontal cortex of APP/PS1KI mice.
    Christensen DZ; Kraus SL; Flohr A; Cotel MC; Wirths O; Bayer TA
    Acta Neuropathol; 2008 Dec; 116(6):647-55. PubMed ID: 18974993
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.